Is this study's primary condition wrong?
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
- The registry's first term
- Myositis
- ClinicalTrials.gg shows
- Dermatomyositis